- Highlighting the challenges for clinical trial design in areas where robust clinical trial data is lacking
- Leveraging real-world data (RWD) to inform QSP disease progression models
- Demonstrating how the QSP-RWD modeling framework was used to establish a target value for early go/no-go decision making
Speaker(s):

Lyndsey Meyer
Principal Scientist
Pfizer